🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

EHF Germany- France Perfect Match!

Congrats for #1st Italian (Südtiroler) Grand Slam #Champion in #Tennis since 1976 Univ.-Prof. Dr. Ralph Stephan von Bardeleben

FDA Approves First Transcatheter Tricuspid Valve Replacement Device dlvr.it/T2D9hp

#Evoque #Tricupid Valve Replacement system achieves #FDA approval as #transcatheter orthotopic #replacement In EU the system was ce mark in Oct 2023 and the 4th CU worldwide and the first commercial pat. Thx in #Mainz TRISCEND II #NUB status I in #Germany. Univ.-Prof. Dr. Ralph Stephan von Bardeleben

⁦Universitätsmedizin Mainz⁩ #press release on #BMG Expertengesprächen Screening und Prävention von #kardiovaskulären und #strukturellen Erkrankungen ⁦Prof. Karl Lauterbach⁩ Impulsepapier #NCD ⁦Deutsche Gesellschaft für Kardiologie⁩ ⁦Deutsche Herzstiftung⁩ #Geriatrie #Kardiologie linkedin.com/posts/von-bard…

#FDA panel circulatory win for #TriClip based on #Triluminate on safety efficacy and benefits outweighing any risks on February 13 2024 DavidAdams ⁦Paul⁩ ⁦Philipp Lurz⁩ ⁦Univ.-Prof. Dr. Ralph Stephan von Bardeleben⁩ @LarsSøndergaard ⁦⁦Erin Spinner⁩ linkedin.com/posts/von-bard…

Early win for #TAVR #TAVi in Germany 1400+ patients with 57% reduction in all cause mortality in low to intermediate risk SAVR mean age 74 years! ⁦Univ.-Prof. Dr. Ralph Stephan von Bardeleben⁩ ⁦Dr. Gilbert Tang⁩ linkedin.com/posts/von-bard…

#NeuesProfilbild

#Edwards Lifesciences acquired #JenaValve and #Endotronix to enhance TAVR in AorticValve Regurgitation and Heartfailure portfolio linkedin.com/posts/von-bard…

#Edwards Lifesciences with intensive M&A acquisition #JenaValve #Endotronix linkedin.com/posts/von-bard…

#SaveTheDate 11th #Mainz #HeartValve #Herzklappen Symposium September 6th-7th, 2024 with free onsite at Hilton Rheinstr. Mainz or worldwide streaming with a security fee. #JoinUs #OneWorld #HeartValves #IntheCenterofEurope #IntheCenterofYourHeart linkedin.com/posts/von-bard…

11th #Mainz Heart Valve Symposium with excellent speakers and faculty onsite free Hilton Mainz and streaming worldwide. Program online at Diaplan.de Sep 6-7th 2024 linkedin.com/posts/von-bard…

Endorsements and participation of the 11th #Mainz Heart Valve Symposium linkedin.com/posts/von-bard…

#joinUS #TeamUM for the 11th #Mainz #Heartvalve Symposium September 6-7th, 2024 with latest 2024 trial data. Onsite free, rebate codes on virtual streaming attendance worldwide and for Healthcare Professionals of middle and lower income countries available linkedin.com/posts/von-bard…

#JoinUS at #TeamUM for the 11th #Mainz #Heartvalve Symposium August 6-7, 2024 with latest trial data and past president of #DGK Prof Stephan Baldus see U there ⁦Univ.-Prof. Dr. Ralph Stephan von Bardeleben⁩ linkedin.com/posts/von-bard…

#joinUs vor the latest Heartvalve trial results in London at #ESC2024 and #Mainz at 11th Heart Valve Symposium with Prof. Stefan Anker #Charite #Berlin and international faculty ⁦Univ.-Prof. Dr. Ralph Stephan von Bardeleben⁩ ⁦thomas modine⁩ ⁦Philipp Lurz⁩ H Treede linkedin.com/posts/von-bard…

#RESHAPE_HF2 MitraClip plus GDMT versus GDMT presented at #ESCcongress and in the #NEJM Stefan Anker Tim Friede Ralph Stephan von Bardeleben ⁦Univ.-Prof. Dr. Ralph Stephan von Bardeleben⁩ ⁦Gregg W. Stone MD⁩ as Discussant with #COAPT and Mitra.fr JF Obadia linkedin.com/posts/von-bard…

First commercial treatment of a #USA patient with the #JenaValve #Trilogy transcatheter Heartvalve #TAVR device ce marked for Aortic Regurgitation or AR in #Mainz #Germany at the ⁦Universitätsmedizin Mainz⁩ #TeamUM with ⁦Univ.-Prof. Dr. Ralph Stephan von Bardeleben⁩ today.Pat well linkedin.com/posts/von-bard…